Skip to content

A study for evaluating the viability of lactic acid bacteria in intestinal tract after ingestion of food containing lactic acid bacteria. Second report, an open trial.

A study for evaluating the viability of lactic acid bacteria in intestinal tract after ingestion of food containing lactic acid bacteria. Second report, an open trial. - A study for evaluating the viability of lactic acid bacteria in intestinal tract after intake of food containing lactic acid bacteria, second report

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000035241
Enrollment
10
Registered
2018-12-13
Start date
2018-12-14
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy volunteers

Interventions

Sponsors

Lotte Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Males and females from 20 to 59 years of age (2) Subjects giving written informed consent

Exclusion criteria

Exclusion criteria: (1) Individuals taking antiflatulents and/or laxatives (including purgative drug) and/or health foods in common use, including food for specified health use and food with function claim (2) Individuals taking antibiotics and/or drugs which influence laxatives(including purgative drugs) in common use (3) Individuals who are not able to stop consumption of foods containing lactic acid bacteria, bifidobacteria, oligosaccharides, dietary fibers, high amount of sugar alcohol and/or other health foods including food for specified health use and food with function claim, which influence intestinal regulation during the study period (4) Individuals presenting known food allergy (5) Individuals who are pregnant or breast-feeding, or have the will of pregnancy during the study period (6) Individuals who are under treatment or have a history of drug/alcohol dependence (7) Individuals who participate in other clinical studies or who are in willing to participate to these studies using foods, drugs and/or cosmetics (8) Individuals who are judged as unsuitable for the study by the investigator

Design outcomes

Primary

MeasureTime frame
Number of viable Lactobacillus brevis in the feces

Secondary

MeasureTime frame
Number of Lactobacillus genus in the feces, number of Bifidobacterium genus in the feces, number of total bacteria in the feces, organic acids content in feces, decay product content in feces

Countries

Japan

Contacts

Public ContactKeishiro Yoshida

Lotte Co., Ltd. Central Laboratory

yoshida_keishirou@lotte.co.jp048-837-0275

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026